A pre-clinical study published in The Lancet on June 25 found that mixing AstraZeneca with a second dose of Pfizer provides "robust" protection from severe COVID-19. The pre-clinical study was ...
The PMCPA has dug into the industry’s LinkedIn activities once again. AstraZeneca received the harshest censure in the latest set of cases, taking a telling-off over one of its own posts, while Pfizer ...
WASHINGTON, DC: U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla in the Oval Office of the White House as he announces a deal with Pfizer to lower drug prices on September 30, ...
Pfizer ended its six-month effort to buy AstraZeneca Monday following the London-based company's May 19 rejection of its last bid of 55 pounds a share in cash and stock. While British takeover law ...
Pfizer PFE and AstraZeneca AZN are two global pharmaceutical leaders with a commanding presence in oncology. For Pfizer, oncology is a key growth driver, accounting for roughly 27% of total company ...
It is still too early to determine any definitive federal policies for 2025 (or beyond) that could affect these companies. However, some analysts have speculated that the administration might restrict ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results